(Q46891052)

26 December 2017

title

Adaptive immunity maintains occult cancer in an equilibrium state (English)

1 reference

26 December 2017

author

Mark J. Smyth

7

1 reference

26 December 2017

William Vermi

object named as

William Vermi

2

0 references

Lloyd J. Old

6

object named as

Lloyd J Old

1 reference

26 December 2017

author name string

Catherine M Koebel

1

1 reference

26 December 2017

Jeremy B Swann

3

1 reference

26 December 2017

Nadeen Zerafa

4

1 reference

26 December 2017

Scott J Rodig

5

1 reference

26 December 2017

Robert D Schreiber

8

1 reference

26 December 2017

language of work or name

English

0 references

publication date

18 November 2007

1 reference

26 December 2017

published in

Nature

1 reference

26 December 2017

volume

450

1 reference

26 December 2017

issue

7171

1 reference

26 December 2017

page(s)

903-907

1 reference

26 December 2017

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNATURE06309

7 January 2021

Cancer immunoediting: from immunosurveillance to tumor escape

1 reference

https://api.crossref.org/works/10.1038%2FNATURE06309

7 January 2021

Suppression of lymphoma and epithelial malignancies effected by interferon gamma

1 reference

https://api.crossref.org/works/10.1038%2FNATURE06309

7 January 2021

NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer

1 reference

https://api.crossref.org/works/10.1038%2FNATURE06309

7 January 2021

The immunobiology of cancer immunosurveillance and immunoediting

1 reference

https://api.crossref.org/works/10.1038%2FNATURE06309

7 January 2021

A critical function for type I interferons in cancer immunoediting

1 reference

https://api.crossref.org/works/10.1038%2FNATURE06309

7 January 2021

The three Es of cancer immunoediting

1 reference

https://api.crossref.org/works/10.1038%2FNATURE06309

7 January 2021

Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity

1 reference

https://api.crossref.org/works/10.1038%2FNATURE06309

7 January 2021

Interferons, immunity and cancer immunoediting

1 reference

https://api.crossref.org/works/10.1038%2FNATURE06309

7 January 2021

Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery

1 reference

https://api.crossref.org/works/10.1038%2FNATURE06309

7 January 2021

Inhibition of methylcholanthrene-induced carcinogenesis by an interferon gamma receptor-dependent foreign body reaction

1 reference

https://api.crossref.org/works/10.1038%2FNATURE06309

7 January 2021

Ki67 protein: the immaculate deception?

1 reference

https://api.crossref.org/works/10.1038%2FNATURE06309

7 January 2021

Ki-67 protein is associated with ribosomal RNA transcription in quiescent and proliferating cells

1 reference

https://api.crossref.org/works/10.1038%2FNATURE06309

7 January 2021

Tumour-dormant states established with L5178Y lymphoma cells in immunised syngeneic murine hosts

1 reference

https://api.crossref.org/works/10.1038%2FNATURE06309

7 January 2021

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

1 reference

https://api.crossref.org/works/10.1038%2FNATURE06309

7 January 2021

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FNATURE06309

7 January 2021

Histological markers of risk and the role of high-grade prostatic intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1038%2FNATURE06309

7 January 2021

Using autopsy series to estimate the disease "reservoir" for ductal carcinoma in situ of the breast: how much more breast cancer can we find?

1 reference

https://api.crossref.org/works/10.1038%2FNATURE06309

7 January 2021

Computed tomography screening and lung cancer outcomes

1 reference

https://api.crossref.org/works/10.1038%2FNATURE06309

7 January 2021

https://api.crossref.org/works/10.1038%2FNATURE06309

1 reference

7 January 2021

A cytokine-mediated link between innate immunity, inflammation, and cancer

1 reference

https://api.crossref.org/works/10.1038%2FNATURE06309

7 January 2021

Differential tumor surveillance by natural killer (NK) and NKT cells.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE06309

7 January 2021

Characterization of the Murine Antigenic Determinant, Designated L3T4a, Recognized by Monoclonal Antibody GK 1.5: Expression of L3T4a by Functional T Cell Clones Appears to Correlate Primarily with Class II MHC Antigen-Reactivity

1 reference

https://api.crossref.org/works/10.1038%2FNATURE06309

7 January 2021

Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNATURE06309

7 January 2021

Costimulation of multiple NK cell activation receptors by NKG2D.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE06309

7 January 2021

Establishment of monoclonal anti-Nk-1.1 antibody.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE06309

7 January 2021

Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice.

1 reference

https://api.crossref.org/works/10.1038%2FNATURE06309

7 January 2021

Identifiers

DOI

10.1038/NATURE06309

1 reference

26 December 2017

Dimensions Publication ID

1000116337

0 references

1 reference

26 December 2017